Revenue from contracts with customers (Tables)

6 Months Ended

Jun. 30, 2026

Summary of disaggregates revenues by major revenue streams

The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.

In alignment with Teva’s Pivot to Growth strategy, commencing January 1, 2026, Anda is no longer reported under Teva’s United States segment. As a result, from that date, Anda is reported as part of the Company’s Other Activities. Prior period amounts were recast to reflect this change.


	Three months ended June 30, 2026
	United States			Europe			International Markets			Other Activities		Total
	(U.S.$ in millions)
Sale of goods		1,704			1,253			527			118		3,602
Licensing arrangements		17			13			7			§		37
Distribution		—			§			20			413		433
Other		(19	)		(3	)		(3	)		95		70

	$	1,702		$	1,263		$	550		$	627	$	4,142

§	Represents an amount less than $0.5 million.


	Three months ended June 30, 2025
	United States		Europe		International Markets		Other Activities			Total
	(U.S.$ in millions)
Sale of goods		1,755		1,275		469		136			3,636
Licensing arrangements		29		9		9		(1	)		46
Distribution		—		§		12		365			377
Other		2		13		5		98			117

	$	1,786	$	1,298	$	495	$	597		$	4,176

§	Represents an amount less than $0.5 million.


	Six months ended June 30, 2026
	United States		Europe		International Markets		Other Activities		Total
	(U.S.$ in millions)
Sale of goods		3,197		2,565		1,003		227		6,991
Licensing arrangements		39		23		15		§		77
Distribution		—		§		38		792		830
Other		1		15		18		192		226

	$	3,236	$	2,603	$	1,074	$	1,211	$	8,124

§	Represents an amount less than $0.5 million.


	Six months ended June 30, 2025
	United States		Europe		International Markets		Other Activities		Total
	(U.S.$ in millions)
Sale of goods		3,270		2,473		1,023		265		7,031
Licensing arrangements		50		16		16		§		82
Distribution		—		§		22		738		760
Other		2		2		17		173		194

	$	3,322	$	2,492	$	1,077	$	1,176	$	8,067

§	Represents an amount less than $0.5 million.

Summary of Sales Reserves and Allowances


	Sales Reserves and Allowances
	Reserves included in Accounts Receivable, net			Rebates			Medicaid and other governmental allowances			Chargebacks			Returns			Other			Total reserves included in Sales Reserves and Allowances			Total
	(U.S.$ in millions)
Balance at January 1, 2026	$	63		$	1,954		$	701		$	937		$	445		$	106		$	4,143		$	4,206
Provisions related to sales made in current year period		186			2,387			596			3,877			130			71			7,061			7,247
Provisions related to sales made in prior periods		—			(47	)		(54	)		(10	)		(12	)		(5	)		(128	)		(128	)
Credits and payments		(190	)		(2,475	)		(566	)		(3,897	)		(153	)		(59	)		(7,150	)		(7,340	)
Translation differences		—			(19	)		(2	)		(4	)		(1	)		(1	)		(27	)		(27	)

Balance at June 30, 2026	$	59		$	1,800		$	675		$	903		$	409		$	112		$	3,899		$	3,958


	Sales Reserves and Allowances
	Reserves included in Accounts Receivable, net			Rebates			Medicaid and other governmental allowances			Chargebacks			Returns			Other			Total reserves included in Sales Reserves and Allowances			Total
	(U.S.$ in millions)
Balance at January 1, 2025	$	56		$	1,674		$	561		$	936		$	399		$	108		$	3,678		$	3,734
Provisions related to sales made in current year period		203			2,520			486			4,034			143			73			7,256			7,459
Provisions related to sales made in prior periods		—			(46	)		30			(28	)		(1	)		(7	)		(52	)		(52	)
Credits and payments		(194	)		(2,363	)		(468	)		(3,962	)		(112	)		(48	)		(6,953	)		(7,147	)
Translation differences		—			64			17			18			5			17			121			121

Balance at June 30, 2025	$	65		$	1,849		$	626		$	998		$	434		$	143		$	4,050		$	4,115